Amcor Plc · NYSE:AMCR
Amcor — Q3 FY2022 Earnings Presentation
23 slides from Amcor's earnings presentation, May 3, 2022
Slide 1: Fiscal 2022 year to date results (nine months ended March 31, 2022)
May 3, 2022 US May 4, 2022 Australia Ron Delia CEO Michael Casamento CFO Fiscal 2022 year to date results (nine months ended March 31, 2022) NYSE: AMCR | ASX: AMC
Slide 2: Disclaimers
Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are genera
Slide 3: Safety
Safety 3 Guided by our values. Committed to our goal of ‘no injuries’ 11.2 4.1 2.0 2.8 2.2 2.1 0.4 Recordable-case frequency rate (per million hours worked) 3Q22 OSHA Includes impact of acquired businesses 2021201520102005 2020 Notes: Recordable cases per 1,000,000 hours worked. All data shown for a
Slide 4: Key messages
Key messages 4 1. Delivered strong March quarter across the business 2. Exceptional management of sales mix and inflation 3. Raised fiscal 2022 EPS guidance 4. Increasing investments for growth
Slide 5: Strong March quarter and year to date financial result
56.2 cents YTD 20.4 cents 3Q $10,635M YTD • $973 million cash returns • $423 million share repurchases • Quarterly dividend increased to 12 cents per share • RoAFE increased to 16% Strong March quarter and year to date financial result 5 Notes: EBIT and EPS presented on an adjusted basis and growth
Slide 6: Growth in priority segments drives mix and margin benefits
6 Growth in priority segments drives mix and margin benefits Notes: MSD is ‘Mid-Single Digit’. Large addressable markets (>$1bn each) Above average growth rates Common segment features: Protein Hot-Fill BeverageHealthcare Premium Coffee Pet Food Hot-Fill Beverage Total Amcor sales >$4 billion across
Slide 7: Flexibles segment
Year to date highlights • Sales of $8.2bn includes price increases of ~$810 million (11% growth) related to higher raw material costs • Sales growth of 3% driven by proactive mix management. Net sales growth up 5% in 3Q • Favorable mix with MSD growth in healthcare, pet food and coffee. • Volumes co
Slide 8: Rigid Packaging segment
Rigid Packaging segment 8 Notes: Non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures including Adjusted EBIT and reconciliations to U.S. GAAP measures can be found in the appendix. Comparable constant currency Δ%
Slide 9: Cash flow, balance sheet & cash returns to shareholders
Cash flow, balance sheet & cash returns to shareholders 9 Notes: Non-GAAP measures exclude items which are not considered representative of ongoing operations. Further details related to non-GAAP measures including Adjusted EBITDA and Adjusted Free Cash Flow and reconciliations to U.S. GAAP measures
Slide 10: Fiscal 2022 guidance
10 Note: Reconciliations of the fiscal 2022 projected non-GAAP measures are not included herein because the individual components are not known with certainty as individual financial statements for fiscal 2022 have not been completed. Fiscal 2022 guidance Amcor’s guidance contemplates a range of fac
Slide 11: Investment case: Strong foundation for growth and value creation
Investment case: Strong foundation for growth and value creation Global leader in primary consumer and healthcare packaging with a strong track record Consistent growth from priority segments, emerging markets and innovation Growing cash flow and strong balance sheet provides ongoing capacity to inv
Slide 12: Multiple drivers of organic growth
Multiple drivers of organic growth Priority Segments Emerging Markets >$3 bn Emerging Markets sales across 27 countries: Driving value through differentiated packaging: Innovation ProteinHealthcare Hot-fill beverage 12 MSD volume growth across Emerging Markets portfolio >$4 bn sales in higher growth
Slide 13: Growing demand for differentiated, sustainable product platforms
Growing demand for differentiated, sustainable product platforms Leveraging our global footprint to expand and localise capacity as demand grows up to 58% reduction in carbon footprint Future investment opportunity Wisconsin Investment underway pre-qualified in the U.S. up to 30% PCR content include
Slide 14: Increasing investments for organic growth
Increasing investments for organic growth 14 Capitalizing on high quality growth opportunities Brazil - Healthcare & Protein UK - Protein Ireland - Healthcare China – Food & Personal care Italy – AmLite Heatflex Increasing capex to 4-5% of sales
Slide 15: Sustainability: Partnering and investing for the future
15 Sustainability: Partnering and investing for the future 15 Exxtend™ Net zero GHG emissions by 2050 Pathway aligned with Science Based Targets Increasing our ambitions Providing insights and expertise Creating demand for recycled material Collaborating with others for long-term impact
Slide 16: Key messages
Key messages 16 1. Delivered strong March quarter across the business 2. Exceptional management of sales mix and inflation 3. Raised fiscal 2022 EPS guidance 4. Increasing investments for growth
Slide 17: Appendix slides
Appendix slides Supplementary schedules and reconciliations
Slide 18: FX translation impact
FX translation impact 18 EUR, 20-30% Other currencies(2), 20-30% USD, 45-55% EUR:USD Euro weakened vs USD, Average USD to EUR rate 3Q22 0.8713 vs 3Q21 0.8414 USD million impact on 3Q22 adjusted net income (4%) (7) Other currencies(2):USD Other currencies weighted average vs USD weakened for 3Q22 vs
Slide 19: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 19
Slide 20: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 20
Slide 21: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 21
Slide 22: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 22
Slide 23: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 23